Suche senden
Hochladen
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabetic Kidney Disease Progression
•
Als PPT, PDF herunterladen
•
5 gefällt mir
•
1,540 views
M
MedicineAndHealthUSA
Folgen
Gesundheit & Medizin
Melden
Teilen
Melden
Teilen
1 von 39
Jetzt herunterladen
Empfohlen
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
Christos Argyropoulos
Diabetes + Kidney disease
Diabetes + Kidney disease
Richard McCrory
Dm and kidney August 23 2019
Dm and kidney August 23 2019
Ala Ali
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes
Prof. Dr. Aswinikumar Surendran
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
MedicineAndFamily
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
SGLT2 inhibitors in Diabetic Kidney Disease
SGLT2 inhibitors in Diabetic Kidney Disease
Christos Argyropoulos
Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019
FarragBahbah
Empfohlen
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
Christos Argyropoulos
Diabetes + Kidney disease
Diabetes + Kidney disease
Richard McCrory
Dm and kidney August 23 2019
Dm and kidney August 23 2019
Ala Ali
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes
Prof. Dr. Aswinikumar Surendran
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
MedicineAndFamily
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
SGLT2 inhibitors in Diabetic Kidney Disease
SGLT2 inhibitors in Diabetic Kidney Disease
Christos Argyropoulos
Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019
FarragBahbah
Role of SGLT2i in cardio-renal protection
Role of SGLT2i in cardio-renal protection
LPS Institute of Cardiology Kanpur UP India
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
MNDU net
How to retard the progression of ckd dr Tareq tantawy
How to retard the progression of ckd dr Tareq tantawy
FarragBahbah
Diabetes mellitus and hypertension
Diabetes mellitus and hypertension
Nadia Shams
Stopdapt 2 randomized clinical trial
Stopdapt 2 randomized clinical trial
Ramachandra Barik
Recent advancement in managing diabetic nephropathy
Recent advancement in managing diabetic nephropathy
pp_shivgunde
Management of hypertension in diabetes
Management of hypertension in diabetes
Dr Karthik Balachandran
Carmelina
Carmelina
Dr. Lalit Agarwal
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
magdy elmasry
Combination therapy in hypertension
Combination therapy in hypertension
Dr Pradip Mate
SGLT2i
SGLT2i
dibufolio
SGLT2 inhibitors
SGLT2 inhibitors
AhmedElBorae1
Advancing Dialysis Hypertension in Dialysis Patients
Advancing Dialysis Hypertension in Dialysis Patients
AdvancingDialysis.org
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
hospital
DYSLIPIDEMIA GUIDELINES
DYSLIPIDEMIA GUIDELINES
arnab ghosh
Hypertension with comorbidity
Hypertension with comorbidity
Aadil Sayyed
diabetic nephropathy- prof-megahed
diabetic nephropathy- prof-megahed
FarragBahbah
Dyslipdemia Guidelines Head to Head
Dyslipdemia Guidelines Head to Head
Mohammad Othman Daoud
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
Christos Argyropoulos
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
Christos Argyropoulos
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
Mohd Hanafi
10 hypertension
10 hypertension
internalmed
Weitere ähnliche Inhalte
Was ist angesagt?
Role of SGLT2i in cardio-renal protection
Role of SGLT2i in cardio-renal protection
LPS Institute of Cardiology Kanpur UP India
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
MNDU net
How to retard the progression of ckd dr Tareq tantawy
How to retard the progression of ckd dr Tareq tantawy
FarragBahbah
Diabetes mellitus and hypertension
Diabetes mellitus and hypertension
Nadia Shams
Stopdapt 2 randomized clinical trial
Stopdapt 2 randomized clinical trial
Ramachandra Barik
Recent advancement in managing diabetic nephropathy
Recent advancement in managing diabetic nephropathy
pp_shivgunde
Management of hypertension in diabetes
Management of hypertension in diabetes
Dr Karthik Balachandran
Carmelina
Carmelina
Dr. Lalit Agarwal
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
magdy elmasry
Combination therapy in hypertension
Combination therapy in hypertension
Dr Pradip Mate
SGLT2i
SGLT2i
dibufolio
SGLT2 inhibitors
SGLT2 inhibitors
AhmedElBorae1
Advancing Dialysis Hypertension in Dialysis Patients
Advancing Dialysis Hypertension in Dialysis Patients
AdvancingDialysis.org
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
hospital
DYSLIPIDEMIA GUIDELINES
DYSLIPIDEMIA GUIDELINES
arnab ghosh
Hypertension with comorbidity
Hypertension with comorbidity
Aadil Sayyed
diabetic nephropathy- prof-megahed
diabetic nephropathy- prof-megahed
FarragBahbah
Dyslipdemia Guidelines Head to Head
Dyslipdemia Guidelines Head to Head
Mohammad Othman Daoud
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
Christos Argyropoulos
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
Christos Argyropoulos
Was ist angesagt?
(20)
Role of SGLT2i in cardio-renal protection
Role of SGLT2i in cardio-renal protection
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
How to retard the progression of ckd dr Tareq tantawy
How to retard the progression of ckd dr Tareq tantawy
Diabetes mellitus and hypertension
Diabetes mellitus and hypertension
Stopdapt 2 randomized clinical trial
Stopdapt 2 randomized clinical trial
Recent advancement in managing diabetic nephropathy
Recent advancement in managing diabetic nephropathy
Management of hypertension in diabetes
Management of hypertension in diabetes
Carmelina
Carmelina
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...
Combination therapy in hypertension
Combination therapy in hypertension
SGLT2i
SGLT2i
SGLT2 inhibitors
SGLT2 inhibitors
Advancing Dialysis Hypertension in Dialysis Patients
Advancing Dialysis Hypertension in Dialysis Patients
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
DYSLIPIDEMIA GUIDELINES
DYSLIPIDEMIA GUIDELINES
Hypertension with comorbidity
Hypertension with comorbidity
diabetic nephropathy- prof-megahed
diabetic nephropathy- prof-megahed
Dyslipdemia Guidelines Head to Head
Dyslipdemia Guidelines Head to Head
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
Andere mochten auch
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
Mohd Hanafi
10 hypertension
10 hypertension
internalmed
World Diabetes Day 2009-2013
World Diabetes Day 2009-2013
International Diabetes Federation
Visita Iglesia 2014 English Version
Visita Iglesia 2014 English Version
Fergus Ducharme
HTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family Med
mdmendoz
Chronic Kidney Disease Silent Epidemic
Chronic Kidney Disease Silent Epidemic
Andre Garcia
Egyptian medicine
Egyptian medicine
Alice James
Diabetes And Kidney
Diabetes And Kidney
arpanbhattacharya
The Dirty Dozen Roadmap Roadblocks (Bruce McCarthy) ProductCamp Boston 2014
The Dirty Dozen Roadmap Roadblocks (Bruce McCarthy) ProductCamp Boston 2014
ProductCamp Boston
How HubSpot Launches Products (and Measures Success) (ProductCamp Boston 2016)
How HubSpot Launches Products (and Measures Success) (ProductCamp Boston 2016)
ProductCamp Boston
Qsp basel nvan riel 4sharing
Qsp basel nvan riel 4sharing
Natal van Riel
Human Inference - Product Update What Do I Know About My Customers
Human Inference - Product Update What Do I Know About My Customers
DataValueTalk
Actividad 2.5
Actividad 2.5
Carlos Salazar Ampuero
ProductCamp Boston - Opening Presentation 2015
ProductCamp Boston - Opening Presentation 2015
ProductCamp Boston
Actividad 3.5
Actividad 3.5
Carlos Salazar Ampuero
ProductCamp Boston - Rolling Promotions Slides (sideways, floor 1)
ProductCamp Boston - Rolling Promotions Slides (sideways, floor 1)
ProductCamp Boston
A vital moderator of sales force competence management and marketing performa...
A vital moderator of sales force competence management and marketing performa...
Alexander Decker
Can a combination of constrained-based and kinetic modeling bridge time scale...
Can a combination of constrained-based and kinetic modeling bridge time scale...
Natal van Riel
Intro and Sponsor Slide Deck - ProductCamp Boston 2013
Intro and Sponsor Slide Deck - ProductCamp Boston 2013
ProductCamp Boston
La didáctica
La didáctica
Carlos Salazar Ampuero
Andere mochten auch
(20)
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
a-comprehensive-approach-to-kidney-disease-and-hypertension by Hazwan
10 hypertension
10 hypertension
World Diabetes Day 2009-2013
World Diabetes Day 2009-2013
Visita Iglesia 2014 English Version
Visita Iglesia 2014 English Version
HTN DM for 3rd Yr Clerkship Family Med
HTN DM for 3rd Yr Clerkship Family Med
Chronic Kidney Disease Silent Epidemic
Chronic Kidney Disease Silent Epidemic
Egyptian medicine
Egyptian medicine
Diabetes And Kidney
Diabetes And Kidney
The Dirty Dozen Roadmap Roadblocks (Bruce McCarthy) ProductCamp Boston 2014
The Dirty Dozen Roadmap Roadblocks (Bruce McCarthy) ProductCamp Boston 2014
How HubSpot Launches Products (and Measures Success) (ProductCamp Boston 2016)
How HubSpot Launches Products (and Measures Success) (ProductCamp Boston 2016)
Qsp basel nvan riel 4sharing
Qsp basel nvan riel 4sharing
Human Inference - Product Update What Do I Know About My Customers
Human Inference - Product Update What Do I Know About My Customers
Actividad 2.5
Actividad 2.5
ProductCamp Boston - Opening Presentation 2015
ProductCamp Boston - Opening Presentation 2015
Actividad 3.5
Actividad 3.5
ProductCamp Boston - Rolling Promotions Slides (sideways, floor 1)
ProductCamp Boston - Rolling Promotions Slides (sideways, floor 1)
A vital moderator of sales force competence management and marketing performa...
A vital moderator of sales force competence management and marketing performa...
Can a combination of constrained-based and kinetic modeling bridge time scale...
Can a combination of constrained-based and kinetic modeling bridge time scale...
Intro and Sponsor Slide Deck - ProductCamp Boston 2013
Intro and Sponsor Slide Deck - ProductCamp Boston 2013
La didáctica
La didáctica
Ähnlich wie Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabetic Kidney Disease Progression
Supra Rx Dose of ARBs
Supra Rx Dose of ARBs
Thitisak Kitthaweesin
Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006
MedicineAndHealthNeurolog
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
Hypertension lecture prof zak (1)
Hypertension lecture prof zak (1)
Professor M Zak Khalil, MD, MRCP (UK), FACC, FESC
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
My Healthy Waist
the po
the po
SoM
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
david7s
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
ueda2015
ภาวะแทรกซ้อนทางไตในผู้ป่วยเบาหวาน
ภาวะแทรกซ้อนทางไตในผู้ป่วยเบาหวาน
CAPD AngThong
Hypertension
Hypertension
Anac09
Macrovascular disease in diabetes
Macrovascular disease in diabetes
PeninsulaEndocrine
2008.02.12 Massie Hyperlipidemia
2008.02.12 Massie Hyperlipidemia
MedicineAndHealthCancer
Hyvet Slide Set
Hyvet Slide Set
Rashidi Ahmad
Diabetic Nephropathy 2009
Diabetic Nephropathy 2009
Joel Topf
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
InsideScientific
Channalging Cases in AHF Hypoperfusion
Channalging Cases in AHF Hypoperfusion
drucsamal
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
Ks doctor
Rosuvastatin
Rosuvastatin
Jahanzaib Sheikh
Diabetic control of ckd patient prof. megahed abo elmagd
Diabetic control of ckd patient prof. megahed abo elmagd
FarragBahbah
Ähnlich wie Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabetic Kidney Disease Progression
(20)
Supra Rx Dose of ARBs
Supra Rx Dose of ARBs
Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
Hypertension lecture prof zak (1)
Hypertension lecture prof zak (1)
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
the po
the po
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
ภาวะแทรกซ้อนทางไตในผู้ป่วยเบาหวาน
ภาวะแทรกซ้อนทางไตในผู้ป่วยเบาหวาน
Hypertension
Hypertension
Macrovascular disease in diabetes
Macrovascular disease in diabetes
2008.02.12 Massie Hyperlipidemia
2008.02.12 Massie Hyperlipidemia
Hyvet Slide Set
Hyvet Slide Set
Diabetic Nephropathy 2009
Diabetic Nephropathy 2009
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Androgens & Cardiovascular Diseases in Women: From Basic Research to Clinical...
Channalging Cases in AHF Hypoperfusion
Channalging Cases in AHF Hypoperfusion
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
Rosuvastatin
Rosuvastatin
Diabetic control of ckd patient prof. megahed abo elmagd
Diabetic control of ckd patient prof. megahed abo elmagd
Mehr von MedicineAndHealthUSA
Prospects for preventing bacterial meningitis Prospects for preventing bact...
Prospects for preventing bacterial meningitis Prospects for preventing bact...
MedicineAndHealthUSA
After Fellowship
After Fellowship
MedicineAndHealthUSA
Salzer
Salzer
MedicineAndHealthUSA
Hiv Infection And The Nervous System
Hiv Infection And The Nervous System
MedicineAndHealthUSA
HIV Vaccine Research and HIV drugs in the pipeline HIV Vaccine Research and...
HIV Vaccine Research and HIV drugs in the pipeline HIV Vaccine Research and...
MedicineAndHealthUSA
Low Back Pain
Low Back Pain
MedicineAndHealthUSA
Thyroid Benign Slides
Thyroid Benign Slides
MedicineAndHealthUSA
The Challenge Of Acute Back Pain
The Challenge Of Acute Back Pain
MedicineAndHealthUSA
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
MedicineAndHealthUSA
Hiv Vaccines Overview
Hiv Vaccines Overview
MedicineAndHealthUSA
Breast Cancer - Is there a link to endocrine disrupting chemicals? Breast C...
Breast Cancer - Is there a link to endocrine disrupting chemicals? Breast C...
MedicineAndHealthUSA
Low Back Pain
Low Back Pain
MedicineAndHealthUSA
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
MedicineAndHealthUSA
How Should One Decide Whom to Treat for Hypertension? How Should One Decide...
How Should One Decide Whom to Treat for Hypertension? How Should One Decide...
MedicineAndHealthUSA
low Back pain
low Back pain
MedicineAndHealthUSA
Calcium disorder
Calcium disorder
MedicineAndHealthUSA
Diabetes Care Alphabet Strategy
Diabetes Care Alphabet Strategy
MedicineAndHealthUSA
Diabetes
Diabetes
MedicineAndHealthUSA
Balasubramanian K5 Oct 21 230pm
Balasubramanian K5 Oct 21 230pm
MedicineAndHealthUSA
Transforming the Office Management of Heart Failure using the Chronic Disease...
Transforming the Office Management of Heart Failure using the Chronic Disease...
MedicineAndHealthUSA
Mehr von MedicineAndHealthUSA
(20)
Prospects for preventing bacterial meningitis Prospects for preventing bact...
Prospects for preventing bacterial meningitis Prospects for preventing bact...
After Fellowship
After Fellowship
Salzer
Salzer
Hiv Infection And The Nervous System
Hiv Infection And The Nervous System
HIV Vaccine Research and HIV drugs in the pipeline HIV Vaccine Research and...
HIV Vaccine Research and HIV drugs in the pipeline HIV Vaccine Research and...
Low Back Pain
Low Back Pain
Thyroid Benign Slides
Thyroid Benign Slides
The Challenge Of Acute Back Pain
The Challenge Of Acute Back Pain
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Hiv Vaccines Overview
Hiv Vaccines Overview
Breast Cancer - Is there a link to endocrine disrupting chemicals? Breast C...
Breast Cancer - Is there a link to endocrine disrupting chemicals? Breast C...
Low Back Pain
Low Back Pain
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
How Should One Decide Whom to Treat for Hypertension? How Should One Decide...
How Should One Decide Whom to Treat for Hypertension? How Should One Decide...
low Back pain
low Back pain
Calcium disorder
Calcium disorder
Diabetes Care Alphabet Strategy
Diabetes Care Alphabet Strategy
Diabetes
Diabetes
Balasubramanian K5 Oct 21 230pm
Balasubramanian K5 Oct 21 230pm
Transforming the Office Management of Heart Failure using the Chronic Disease...
Transforming the Office Management of Heart Failure using the Chronic Disease...
Kürzlich hochgeladen
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Dipal Arora
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
Neha Kaur
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
CALL GIRLS
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
narwatsonia7
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
discovermytutordmt
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
aartirawatdelhi
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
chandars293
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
Taniya Sharma
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
Dipal Arora
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
vidya singh
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Dipal Arora
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
jageshsingh5554
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Suhani Kapoor
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Dipal Arora
Kürzlich hochgeladen
(20)
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabetic Kidney Disease Progression
1.
Hypertension and Diabetic
Kidney Disease Progression George L. Bakris, MD Professor and Vice-Chairman Dept. of Preventive Medicine Director, Hypertension/Clinical Research Center Rush University Medical Center Chicago, IL 60612 ©2006. American College of Physicians. All Rights Reserved.
2.
3.
Increasing Prevalence of
Diagnosed Diabetes in US Adults Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/diabetes/statistics/prev/state/fig61994and2002.htm. Accessed August 30, 2004. 1994 2002 <4% 4–4.9% 5–5.9% 6% ©2006. American College of Physicians. All Rights Reserved.
4.
Increasing Prevalence of
Obesity* Among US Adults Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm. Accessed August 30, 2004. *BMI ≥ 30 kg/m 2 . 10%–14% 15%–19% 20%–24% ≥ 25% 2002 ©2006. American College of Physicians. All Rights Reserved. 1994
5.
Walking the dog
©2006. American College of Physicians. All Rights Reserved.
6.
Incidence of Kidney
Failure per million population, 1990, by HSA, unadjusted ©2006. American College of Physicians. All Rights Reserved.
7.
Incidence of Kidney
Failure per million population, 2000, by HSA, unadjusted ©2006. American College of Physicians. All Rights Reserved.
8.
Diabetes: The Most
Common Cause of ESRD Primary Diagnosis for Patients Who Start Dialysis Glomerulonephritis 13% Other 10% United States Renal Data System. Annual data report. 2000. No. of patients Projection 95% CI 1984 1988 1992 1996 2000 2004 2008 0 100 200 300 400 500 600 700 r 2 =99.8% 243,524 281,355 520,240 No. of dialysis patients (thousands) ©2006. American College of Physicians. All Rights Reserved. Diabetes 50.1% Hypertension 27%
9.
Cardiovascular Comorbidities,
5% Medicare sample, by Diabetes and CKD status, 1999-2000 %Stroke/TIA %ASHD %Amputation/PVD %Heart Failure ©2006. American College of Physicians. All Rights Reserved.
10.
Level of Kidney
Function Is an Independent Risk Factor For CV Risk N=15,350 Mean follow-up=6.2 years Age -45-64 Stage of Kidney Disease N Stage 2 (GFR-60-89) 7,665 Stage 3 &4 (GFR-15-59) 444 1.0 1.25 1.75 1.5 2.0 1.38 1.16 Manjunath G et.al JACC 2003;41:47-55 0.75 ©2006. American College of Physicians. All Rights Reserved.
11.
Go, A. S.
et al. N Engl J Med 2004;351:1296-1305 ©2006. American College of Physicians. All Rights Reserved.
12.
13.
CKD Prevalence in
US (AJKD 2002) GFR (ml/min) <15 15-29 30-59 60-89 > 90 ©2006. American College of Physicians. All Rights Reserved.
14.
15.
Microalbuminuria Albuminuria (Proteinuria)
mg/day CV Risk and Vascular Dysfunction CV Risk and Presence of Renal Dysfunction and Vascular Dysfunction Normal ©2006. American College of Physicians. All Rights Reserved.
16.
Proteinuria Predicts Stroke
and CHD Events in Type 2 Diabetes P <0.001 40 30 20 10 0 Stroke CHD Events 80 60 40 20 0 0.5 0.6 0.7 0.8 0.9 1 Survival Curves For CV Mortality Overall: P <0.001 C B A Incidence (%) Months Miettinen H et al. Stroke . 1996;27:2033-2039. B: U-Prot 150–300 mg/L A: U-Prot <150 mg/L C: U-Prot >300 mg/L 0 U-Prot = Urinary protein concentration. 100 ©2006. American College of Physicians. All Rights Reserved.
17.
Berton G et.al.
Diabetologia, Aug. 2004 Kaplan-Meier curves of 3-year all-cause mortality in the AMI patients stratified by DM status and ACR > 30 µ g/mg or <30 µ g/mg on the 3rd day after admission ©2006. American College of Physicians. All Rights Reserved.
18.
Use of MAU,
CRP, and BNP as Predictors of Mortality and CV Events Mortality Hazard Ratio ( 95% CI ) for Values Above 80 th Percentile NT-proBNP CRP MAU First Major CV Event NT-proBNP CRP MAU P=.007 P=014 P=.008 P=.003 P=.96 P=<.001 Adjusted for age, sex, smoking, DM, HTN, Afib, LVEF<50%, LVH, total cholesterol, serum creatinine. Mortality analysis based on 91 deaths, and CV event data based on 63 events due to missing covariates. The 80 th percentile corresponds to values more than 5.85 pg/mL for NT-proBNP, 5.76 mg/L for CRP, and 18.4 mg/g for MAU. Kistorp K, et al. JAMA . 2005;293:1609-1616. ©2006. American College of Physicians. All Rights Reserved. 0 0.5 1 1.5 2 3 4 5
19.
Predictive value of
antiproteinuric effect on renal protection 0 -5 5 10 15 -100 -50 0 50 100 Rate of decline in GFR (ml/min/ year) r = 0.47 p < 0.011 delta Proteinuria (% change from pretreatment ) Apperloo AJ et al; Kidney Int 1994; 45:S174-8. Rossing P et al. Diabetologia. 1994;37:511-516. 15 10 5 0 -5 -100 -50 0 50 100 r=0.73 p<.001. Diabetes Non-Diabetes ©2006. American College of Physicians. All Rights Reserved.
20.
21.
IDNT Proportion of
Patients with the Primary Composite Endpoint* Proportion with primary endpoint 0 6 12 18 24 30 36 42 48 54 579 555 528 496 400 304 216 146 65 565 542 508 474 385 287 187 128 46 568 551 512 471 401 280 190 122 53 Irbesartan (n) Amlodipine (n) Placebo (n) Months of Follow-up *Composite of a doubling of serum creatinine, end stage renal disease, or death P=0.02 for irbesartan compared to placebo Lewis EJ, et al. N Engl J Med. 2001;345(12):851-860. ©2001 Massachusetts Medical Society. All rights reserved. ©2006. American College of Physicians. All Rights Reserved.
22.
Relationship Between Rate
of Decline in Renal Function and Change in Proteinuria in IDNT Lewis EJ et al. N Engl J Med . 2001;345:851-860. Amlodipine Irbesartan Placebo Creatinine clearance (mL/min/1.73 m 2 ) Proteinuria (g/d) ©2006. American College of Physicians. All Rights Reserved. -8 -7 -6 -5 -4 -3 -2 -1 0
23.
RENAAL; Baseline Proteinuria
as a Determinant for Cardiac Events in Type 2 diabetes CV Endpoint Heart Failure 0 2 4 6 Hazard ratio 5.25 Albuminuria (g/g) 0 2 4 6 <.5 2.0 2.95 4.4 5.25 Albuminuria (g/g) <.5 2.0 2.95 4.4 Hazard ratio De Zeeuw et al; Circulation 2004 (adjusted for all conventional risk factors) ©2006. American College of Physicians. All Rights Reserved.
24.
RENAAL; Baseline Proteinuria
as a Determinant for RENAL Events in Type 2 Diabetes De Zeeuw et al; Kidney Int 2004 Primary composite Endpoint 0 10 15 5 Hazard ratio <.5 2.0 2.95 4.4 5.25 Baseline Albuminuria (g/g) Baseline Albuminuria (g/g) 0 <.5 2.0 2.95 4.4 5.25 ESRD Hazard ratio (adjusted for all conventional risk factors) ©2006. American College of Physicians. All Rights Reserved. 10 20 30
25.
26.
27.
28.
29.
30.
Angiotensin-Receptor Blockade versus
Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy-RESULTS Barnett AH et.al N Engl J Med 2004;351:1952-1961. Baseline GFR 91 ml/min ©2006. American College of Physicians. All Rights Reserved.
31.
Effects of ACE
Inhibitors or ARBs on Renal Disease Progression: A Meta-Analysis Cases J et.al. Lancet 2005;366:2026 ESRD 2X SCr ©2006. American College of Physicians. All Rights Reserved.
32.
Effects of ACE
Inhibitors or ARBs on Renal Disease Progression: A Meta-Analysis Cases J et.al. Lancet 2005;366:2026 ESRD 2X SCr ©2006. American College of Physicians. All Rights Reserved.
33.
-9.4 -1.3 -4
-7 -10 -8 -6 -4 -2 0 mL/min/yr. mm Hg Initial GFR Rate of Decline [<4 Months] 130 140 150 Systolic Pressure Trial End Bakris (N = 18) Nielsen (N = 21) Final GFR Rate of Decline [Trial End (1–6 years)] 136 154 Bakris GL & Weir M Arch Intern Med. 2000:160:685-693 Effect Of Early And Late Changes In GFR When Blood Pressure Is Controlled with an ACE Inhibitor ©2006. American College of Physicians. All Rights Reserved.
34.
35.
36.
37.
Percentage of Adults
with Diabetes Who Achieved Recommended Goals of Cardiovascular Risk Factors in NHANES Saydah S et.al JAMA 2004;291:335 % ©2006. American College of Physicians. All Rights Reserved.
38.
( if
systolic BP > 20 mmHg above goal ) START with ACEI or ARB/thiazide diuretic*) If BP Still Not at Goal (130/80 mm Hg) If BP Still Not at Goal (130/80 mm Hg) or If used CCB, Add Other Subgroup of CCB (ie, amlodipine-like agent if verapamil or diltiazem already being used and the converse) OR if blocker used add CCB Add Vasodilator (hydralazine, minoxidil) OR Refer to a Clinical Hypertension Specialist If BP Still Not at Goal (130/80 mm Hg) Add Long Acting Thiazide Diuretic* If Blood Pressure >130/80 mm Hg in Diabetes or Chronic Kidney Disease with Any Level of Albuminuria Recheck within 2-3 weeks Recheck within 2-3 weeks Recheck within 4 weeks ( if systolic BP< 20 mmHg above goal ) Start ARB or ACE Inhibitor titrate upwards Add CCB or blocker** (titrate dose upward) Ashgar and Bakris, Primer of Kidney Diseases, 2005 Consider low dose aldosterone antagonists# ©2006. American College of Physicians. All Rights Reserved.
39.
Jetzt herunterladen